Perkins Capital Management Inc Amarin Corp Plcuk Transaction History

Perkins Capital Management Inc

$102 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$0.63 - $1.07 $5,796 - $9,844	-9,200 Reduced 38.82%	14,500 $10,000
Q1 2024 May 09, 2024	BUY	$0.82 - $1.35 $983 - $1,620	1,200 Added 5.33%	23,700 $21,000
Q3 2023 Nov 02, 2023	SELL	$0.85 - $1.43 $2,550 - $4,290	-3,000 Reduced 11.76%	22,500 $21,000
Q2 2023 Jul 21, 2023	SELL	$1.12 - $1.49 $3,360 - $4,470	-3,000 Reduced 10.53%	25,500 $30,000
Q1 2023 May 09, 2023	BUY	$1.19 - $2.19 $3,570 - $6,570	3,000 Added 11.76%	28,500 $43,000
Q4 2022 Jan 26, 2023	SELL	$1.07 - $1.34 $6,955 - $8,710	-6,500 Reduced 20.31%	25,500 $31,000
Q3 2022 Oct 24, 2022	SELL	$1.09 - $1.67 $3,270 - $5,010	-3,000 Reduced 8.57%	32,000 $35,000
Q2 2022 Jul 29, 2022	BUY	$1.13 - $3.69 $11,299 - $36,900	10,000 Added 40.0%	35,000 $52,000
Q1 2022 Apr 20, 2022	BUY	$2.85 - $3.73 $1,425 - $1,865	500 Added 2.04%	25,000 $82,000
Q4 2021 Feb 10, 2022	BUY	$3.24 - $5.18 $16,848 - $26,936	5,200 Added 26.94%	24,500 $83,000
Q3 2021 Oct 25, 2021	BUY	$3.94 - $5.84 $2,364 - $3,504	600 Added 3.21%	19,300 $98,000
Q2 2021 Jul 28, 2021	BUY	$4.26 - $6.5 $8,520 - $13,000	2,000 Added 11.98%	18,700 $82,000
Q1 2021 Apr 28, 2021	BUY	$5.03 - $8.8 $1,006 - $1,760	200 Added 1.21%	16,700 $104,000
Q4 2020 Feb 09, 2021	SELL	$4.04 - $5.31 $10,908 - $14,336	-2,700 Reduced 14.06%	16,500 $81,000
Q3 2020 Oct 28, 2020	BUY	$3.64 - $7.76 $6,552 - $13,968	1,800 Added 10.34%	19,200 $81,000
Q1 2020 Apr 29, 2020	SELL	$4.0 - $21.53 $12,400 - $66,743	-3,100 Reduced 15.12%	17,400 $70,000
Q4 2019 Feb 03, 2020	SELL	$13.94 - $24.12 $13,940 - $24,120	-1,000 Reduced 4.65%	20,500 $440,000
Q3 2019 Oct 23, 2019	SELL	$13.89 - $23.16 $12,501 - $20,844	-900 Reduced 4.02%	21,500 $326,000
Q2 2019 Aug 09, 2019	SELL	$16.27 - $20.51 $17,897 - $22,561	-1,100 Reduced 4.68%	22,400 $434,000
Q1 2019 Apr 22, 2019	SELL	$12.61 - $22.33 $75,660 - $133,980	-6,000 Reduced 20.34%	23,500 $488,000
Q4 2018 Feb 11, 2019	SELL	$12.41 - $22.98 $31,025 - $57,450	-2,500 Reduced 7.81%	29,500 $401,000
Q3 2018 Oct 22, 2018	SELL	$2.45 - $16.27 $2,450 - $16,270	-1,000 Reduced 3.03%	32,000 $521,000
Q2 2018 Aug 02, 2018	SELL	$2.68 - $3.48 $26,800 - $34,800	-10,000 Reduced 23.26%	33,000 $102,000
Q1 2018 Apr 23, 2018	SELL	$2.99 - $4.44 $28,106 - $41,736	-9,400 Reduced 17.94%	43,000 $129,000
Q4 2017 Jan 26, 2018	BUY	$3.06 - $4.09 $8,568 - $11,452	2,800 Added 5.65%	52,400 $210,000
Q3 2017 Oct 31, 2017	BUY	$3.03 - $3.72 $150,288 - $184,512	49,600	49,600 $174,000

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$10.9 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$5.46 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$1.46 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.12 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.1 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account